Smart ring maker Oura pocketed an additional $125 million following a $75 million investment from medical device maker Dexcom ...

Oura announced today that it completed a $200 million Series D funding round with investment from Dexcom (Nasdaq:DXCM).

Smart ring maker Oura announced on Thursday that it has closed a $200 million Series D funding round, bringing the company’s ...

Finnish health tech firm Oura has closed a $200M Series D funding round that boosts its market valuation to $5.2B. The smart ...

The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co.

After years of wearable technology companies eating each other, Oura has been a beacon of success. And the company is now ...

Remodel Health, a company that helps insurance brokers offer individual coverage health reimbursement arrangement plans, ...

Oura’s series D round of funding included participation from Fidelity Management & Research company and glucose monitoring company Dexcom. The $200 million in funding brings Oura’s total valuation to ...

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

Dexcom’s OTC glucose biosensor Stelo is the first product to use the GenAI platform for improved weekly insights.

Finnish health technology company ŌURA has secured $200m in a Series D funding round, raising the company's valuation to ...

Oura Health Oy, the maker of health-tracking smart device Oura Ring, said today it has raised $200 million in a new late-stage funding, doubling its valuation since 2022 to $5.2 billion. Fidelity ...